✦ LIBER ✦

232 Final Results of a Phase II Study of the Combination of Oral Vinorelbine (NVBo), Capecitabine (X) and Trastuzumab (H) in HER2-positive Metastatic Breast Cancer (MBC)

✍ Scribed by L. Petruzelka; V. Ganju; P.F. Conte; N. Tubiana-Mathieu; F. Majois; M. Espie; A. Llombart; M. Gil Gil; G. Villanova; A. Chan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-line trastuzumab (H), oral vinorel

✍ A. Chan; V. Ganju; D. Becquart; P.F. Conte; L. Petruzelka; L. Goedhals; M. Gil G 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 74 KB

5055 High efficacy of the combination of

✍ A. Chan; V. Ganju; D. Becquart; P.F. Conte; L. Petruzelka; M. Gil-Gil; M. Morand 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

All-oral vinorelbine (NVBo) and capecita

✍ N. Tubiana-Mathieu; P. Bougnoux; D. Becquart; A. Chan; F. Majois; M. Espie; R. P 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

2124 POSTER Triple combination of oral v

✍ A. Chan; V. Ganju; D. Becquart; P.F. Conte; L. Petruzelka; O. Perrot; G. Villano 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 78 KB

A phase II study of bevacizumab in combi

✍ Lin, N. U.; Seah, D. S.; Gelman, R.; Desantis, S.; Mayer, E. L.; Isakoff, S.; Di 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 258 KB

A phase II study of oral vinorelbine (NV

✍ V. Trillet-Lenoir; T. Delozier; M. Lichinister; D. Gédouin; P. Bougnoux 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 334 KB